Seres Therapeutics (MCRB)'s 30-day implied volatility (IV30) was 69.1% at the close on October 15, 2026, down from 70.5% the day before, against a 52-week range of 61.9% to 174.4%. Its 20-day historical volatility was 95.2%.
Data as of October 15, 2026.